Preclinical studies using xenograft mouse models demonstrated that B7-H3 silencing inhibited tumor growth, indicating that B7-H3 may exacerbate the severity of NB by modulating the Stat3/c-Met pathway and augmenting glucose turnover in cancer cells [73], findings that align with recent studies by Wu et al. in lung cancer. This evidence concerns the gene CD276 and cancer.